HMC
QTTB icon

Harvard Management Company’s Q32 Bio QTTB Stock Holding History

Harvard Management Company’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-162,965
Closed -$7.27M – 19
2024
Q3 		$7.27M Hold
162,965
– – 0.42% 12
2024
Q2 		$2.93M Buy
+162,965
New +$3.9M 0.18% 14

Other funds holding QTTB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Harvard Management Company's QTTB Position: Q4 2024 in Review

Harvard Management Company sold out of Q32 Bio (QTTB) in Q4 2024, closing a stake of 162,965 shares — an estimated $7.27M sold.

Harvard Management Company first reported a position in QTTB in Q2 2024 and held it in 2 quarters. The position peaked at $7.27M in Q3 2024. 92 funds tracked by Wall St. Rank hold QTTB as of Q4 2024.

  • Harvard Management Company reported no remaining Q32 Bio position as of Q4 2024 after selling out during the quarter.
  • Harvard Management Company sold 162,965 Q32 Bio shares in Q4 2024, an estimated $7.27M.
  • Harvard Management Company first reported a position in Q32 Bio in Q2 2024 and held it in 2 quarters.
  • Harvard Management Company's Q32 Bio position peaked at $7.27M in Q3 2024.
  • 92 funds tracked by Wall St. Rank held Q32 Bio as of Q4 2024.

Based on Harvard Management Company's 13F filing for Q4 2024, filed 14 Feb 2025.